RARRES2 and cardiovascular disorder: Studies must include participants without comorbidities known to influence serum chemerin levels, such as type 2 diabetes, metabolic syndrome, cardiovascular diseases, chronic kidney disease, or other autoimmune/inflammatory conditions.